The current research study provides evidence that administering niclosamide effectively mitigates a broad spectrum of disease features associated with ALS in both SOD1-G93A and FUS transgenic mouse models, characterised by different molecular disease determinants. Here, FUS is linked to amyotrophic lateral sclerosis.